Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 54,318,000 | 58,054,000 | 56,197,000 | 45,804,000 | 33,266,000 |
| Cost of Goods | 20,415,000 | 17,414,000 | 17,446,000 | 15,387,000 | 7,439,000 |
| Gross Profit | 33,903,000 | 40,640,000 | 38,751,000 | 30,417,000 | 25,827,000 |
| Operating Expenses | 21,146,000 | 22,523,000 | 20,827,000 | 19,054,000 | 12,844,000 |
| Operating Income | 12,757,000 | 18,117,000 | 17,924,000 | 11,363,000 | 12,983,000 |
| Interest Expense | 1,684,000 | 2,044,000 | 2,384,000 | 2,280,000 | 1,509,000 |
| Other Income | -4,823,000 | -2,596,000 | -2,551,000 | -5,685,000 | -3,048,000 |
| Pre-tax Income | 6,250,000 | 13,477,000 | 12,989,000 | 3,398,000 | 8,426,000 |
| Income Tax | 1,377,000 | 1,632,000 | 1,440,000 | -1,224,000 | 544,000 |
| Net Income Continuous | 4,873,000 | 11,845,000 | 11,549,000 | 4,622,000 | 7,882,000 |
| Minority Interests | 10,000 | 9,000 | 7,000 | 6,000 | N/A |
| Net Income | $4,863,000 | $11,836,000 | $11,542,000 | $4,616,000 | $7,882,000 |
| EPS Basic Total Ops | 2.73 | 6.65 | 6.48 | 2.73 | 5.30 |
| EPS Basic Continuous Ops | 2.76 | 6.69 | 6.52 | 2.77 | 5.32 |
| EPS Diluted Total Ops | 2.72 | 6.63 | 6.45 | 2.72 | 5.28 |
| EPS Diluted Continuous Ops | 2.75 | 6.66 | 6.50 | 2.76 | 5.31 |
| EPS Diluted Before Non-Recurring Items | 11.11 | 13.77 | 12.70 | 10.56 | 8.94 |
| EBITDA(a) | $21,455,000 | $26,584,000 | $26,445,000 | $17,834,000 | $15,000,000 |